Bill takes aim at Apple and Google app-store tactics, senator calls it ‘craven textbook abuse’ that harms consumers

Bill introduced by Sens. Blackburn, Blumenthal and Klobuchar takes aim at Big Tech companies requiring payment through their systems and competing against independent app developers while charging fees of up to 30% of sales

Sen. Richard Blumenthal, D-Conn., told MarketWatch on Wednesday that Apple Inc. and Google "are so beyond the pale in their abusive tactics. It is a blatant, craven textbook abuse of economic power."

Stefani Reynolds/Getty Images

Referenced Symbols

Senators introduced a bipartisan bill Wednesday that seeks to rein in the control Google and Apple Inc. have over their respective mobile-app stores, part of a larger wave of antitrust legislation in congress.

The Open App Markets Act bill’s co-authors — Sens. Richard Blumenthal, D-Conn., Marsha Blackburn, R-Tenn., and Amy Klobuchar, D-Minn. — would set rules to protect competition and strengthen consumer protection in the app market currently dominated by Alphabet Inc.’s Google GOOGL, -0.16% GOOG, -0.27% and Apple. AAPL, +0.21%. Among the rules: Apple and Google would no longer be able to require developers to exclusively use their app payment systems nor would the two companies be allowed to favorably price and rank their apps against competing brands.

Developers would be allowed to sue for injunctive relief.

“They [Apple and Google] are so beyond the pale in their abusive tactics. It is a blatant, craven textbook abuse of economic power,” Blumenthal told MarketWatch in a phone interview shortly before the bill was introduced. “Sometimes the abuses by Big Tech are abstract, but here the impact is very direct on consumers [via a 30% commission fee] and in the stifling of innovation through ‘copy and kill’ app tactics.”

Apple and Google reach billions of consumers through the App Store and Google Play Store, respectively. But their onerous commission fees of up 30% for developers have sparked high-profile lawsuits and constant grumbling. Equally vexing for developers is a tendency by Apple and Google to offer their own versions of popular apps from third-party developers.

“Big Tech giants are forcing their own app stores on users at the expense of innovative startups,” Sen. Blackburn added in a statement. “Apple and Google want to prevent developers and consumers from using third-party app stores that would threaten their bottom line. Their anticompetitive conduct is a direct affront to a free and fair marketplace.”

Apple and Google make billions from their respective app stores. Apple recorded gross profit of $35.5 billion on revenue of $53.8 billion last fiscal year in its Services segment, which includes App Store sales along with subscription services and other online offerings, and has already cleared nearly as much in the first three quarters of its current fiscal year, $34.8 billion in gross income on revenue of $50.1 billion. Google’s Play Store revenue is included with other services as well, and the segment produced sales of $21.7 billion last year and more than $13 billion in the first half of this year.

Apple did not respond to a request for comment before the time of publication. Google declined to comment on the bill, but the company has said Android provides choice that others — presumably Apple — do not. This includes the ability of device makers and carriers to preload competing app stores alongside Google Play on their device, as well as the ability of consumers to “sideload” apps, which means they can download them from a developer’s website directly without going through Google Play.

Blumenthal pointed to a Senate hearing in April, when executives from Tile Inc., Spotify Technology SPOT, -1.39%, and Match Group Inc. MTCH, +0.88% testified to the frustrations and antagonisms in working as developers on Apple and Google’s platforms.

Jared Sine, Match’s chief legal officer, claimed Google called Match the night before his testimony became public to press why his testimony differed from Match’s comments in its latest earnings call. Blumenthal quickly jumped on the call as “potentially actionable.”

“Big Tech are gatekeepers who operate their own platforms and products,” Blumenthal told MarketWatch on Wednesday. “It’s like the Lords during Medieval times saying how well serfs did under their benevolent control.”

The bill was in the works before Epic Games Inc., maker of the popular Fortnite game, sued Apple over its App Store policies in an attempt to operate its own payment service within the App Store, according to Blumenthal. A decision in the Epic-Apple case could come as soon as this month.

Epic vs. Apple: The (predicted) verdict is in

The app store bill joins a raft of Congressional legislation. In June, House Democrats, led by Rep. David Cicilline of Rhode Island, introduced a package of bills to shake up the U.S. antitrust climate. The most aggressive would let prosecutors sue to break up major tech companies by forcing the platforms to sell off lines of business if they represent a conflict of interest. Another bill under consideration would prohibit online platforms such as Amazon from giving their own products or services an advantage over those of rivals that depend on the same platforms to reach consumers.

Meanwhile, Klobuchar, chairwoman of the Subcommittee on Competition Policy, Antitrust, and Consumer Rights, is working on broad, general antitrust reform that would seek bipartisan support. Antitrust experts expect Klobuchar’s legislation to apply to tech and other industries.

Read Next

Read Next

Moderna shares slide 16% after bearish BofA note, putting them on track for biggest percentage decline since May 2020

Moderna Inc. shares undefined tumbled 16% Wednesday to put them on track for their biggest percentage decline since May of 2020, according to Dow Jones data. The stock has now fallen for four of the past five days and has lost more than 20% in a two-day period. On Tuesday, BofA analyst Geoff Meacham published a bearish note on the company that questioned its valuation after its market cap grew to almost $200 billion, putting it ahead of far more established drug companies like the 40-year-old Amgen undefined, currently valued at about $129.3 billion, and the 130-year old Merck undefined, valued at about $189.7 billion. According to Meachem's analysis, it should be about 75% below its current price. While Moderna's COVID-19 vaccine has been a major contributor to its market cap, to justify $200 billion in value, one would have to assume two things: Moderna would deliver 1 billion to 1.5 billion doses of its COVID-19 vaccine each year through 2038; and its entire pipeline will be 100% successful. That currently involves four programs in Phase 2 trials, 10 Phase 1 programs and eight preclinical programs not yet in human testing, for total peak sales of $30 billion. Moderna's recent revenue has come to about $7 billion in the past four quarters. Shares have gained 266% in the year to date, while the SPDR S&P Biotech ETF undefined has fallen 11% and the S&P 500 undefined has gained 18%.

More On MarketWatch

About the Author